Conference · London, United Kingdom
Cancer Biomarker Discovery and Assay Development
Science · Life Sciences · Medicine
Key numbers
- Editions on record
- 1first in 2014
About Cancer Biomarker Discovery and Assay Development
Whilst numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers are already being used at some point in patient care. This event will discuss the further discovery and assay development of genetic, epigenetic, proteomic, glycomic, and imaging biomarkers which can be used for cancer diagnosis, prognosis, and epidemiology. We provide an informal atmosphere for discussion and debate. This is an ideal setting for experts to present their work and discuss their findings
Who Should Attend
Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers
Speakers Include:
Dr Massimo Pancione, PhD Researcher of Molecular Biology, University of Sannio, Italy
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 13 May 2014 | Cineworld The O2 London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Cancer Biomarker Discovery and Assay Development?
The next dates haven't been confirmed. The last edition we have on record was 13 May 2014.
Where is it held?
The last edition we have was at Cineworld The O2, London, United Kingdom.